` CBLL (CeriBell Inc) vs S&P 500 Comparison - Alpha Spread

C
CBLL
vs
S&P 500

Over the past 12 months, CBLL has underperformed S&P 500, delivering a return of -8% compared to the S&P 500's +13% growth.

Stocks Performance
CBLL vs S&P 500

Loading
CBLL
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
CBLL vs S&P 500

Loading
CBLL
S&P 500
Difference
www.alphaspread.com

Performance By Year
CBLL vs S&P 500

Loading
CBLL
S&P 500
Add Stock

Competitors Performance
CeriBell Inc vs Peers

CeriBell Inc
Glance View

Market Cap
559.3m USD
Industry
Health Care

Ceribell, Inc. is a commercial-stage medical technology company, which focuses on transforming the diagnosis and management of patients with serious neurological conditions. The company is headquartered in Sunnyvale, California and currently employs 281 full-time employees. The company went IPO on 2024-10-11. The company is focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Point-of-Care EEG enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies. Its Clarity AI algorithm interprets EEG in real-time, provides bedside alerts and continuous monitoring for status epilepticus. The Ceribell EEG Portal makes it easy to remotely review EEG in real-time with pre-annotated EEG insights.

CBLL Intrinsic Value
12.98 USD
Overvaluation 17%
Intrinsic Value
Price
C
Back to Top